In summary, the current study demonstrates that the Ki67 index is an accurate prognostic and, most importantly, predictive marker in epithelioid MPM, indicating the proportion of proliferating tumor cells and reflecting a more aggressive biological behavior translating to a lower treatment responsiveness to multimodality therapy strategies in the clinical setting. Here, MKI67 is linked to neoplasm.